Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$4.91 USD
+0.04 (0.82%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.90 -0.01 (-0.20%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum C VGM
Earnings News For AUPH
-
Aurinia: Q4 Earnings Snapshot
-
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
-
Aurinia: Q3 Earnings Snapshot
-
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
-
Aurinia: Q1 Earnings Snapshot
-
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
-
Aurinia: Q4 Earnings Snapshot
-
Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates
-
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Should You Buy?
-
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
-
Aurinia: Q3 Earnings Snapshot
-
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
-
Aurinia: Q2 Earnings Snapshot
-
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals (AUPH) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
-
Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for